TCM
ERNA icon

Tradewinds Capital Management’s Eterna Therapeutics ERNA Stock Holding History

Tradewinds Capital Management’s Portfolio ERNA Stock Details ERNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.4K Buy
+361
New +$2.56K ﹤0.01% 544

Other funds holding ERNA

AssetMark Inc
AssetMark Inc Concord, California $58.2B AUM 22.78% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return

Tradewinds Capital Management's ERNA Position: Q2 2026 in Review

Tradewinds Capital Management opened a new position in Eterna Therapeutics (ERNA) in Q2 2026: 361 shares worth $2.4K. The stake represents ﹤0.01% of the portfolio and ranks #544 among its holdings.

3 funds tracked by Wall St. Rank hold ERNA as of Q2 2026.

  • Tradewinds Capital Management held 361 shares of Eterna Therapeutics worth $2.4K as of Q2 2026.
  • Eterna Therapeutics was a new Tradewinds Capital Management position in Q2 2026.
  • Eterna Therapeutics made up ﹤0.01% of Tradewinds Capital Management's portfolio in Q2 2026, its #544 holding.
  • 3 funds tracked by Wall St. Rank held Eterna Therapeutics as of Q2 2026.

Based on Tradewinds Capital Management's 13F filing for Q2 2026, filed 24 Jul 2026.